Shenzhen Change In Cash vs Net Borrowings Analysis

002551 Stock

3.38 0.08 2.42%

Shenzhen Glory financial indicator trend analysis is much more than just breaking down Shenzhen Glory Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shenzhen Glory Medical is a good investment. Please check the relationship between Shenzhen Glory Change In Cash and its Net Borrowings accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Change In Cash vs Net Borrowings

Change In Cash vs Net Borrowings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shenzhen Glory Medical Change In Cash account and Net Borrowings. At this time, the significance of the direction appears to have weak relationship.

The correlation between Shenzhen Glory's Change In Cash and Net Borrowings is 0.38. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Net Borrowings in the same time period over historical financial statements of Shenzhen Glory Medical, assuming nothing else is changed. The correlation between historical values of Shenzhen Glory's Change In Cash and Net Borrowings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Shenzhen Glory Medical are associated (or correlated) with its Net Borrowings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Borrowings has no effect on the direction of Change In Cash i.e., Shenzhen Glory's Change In Cash and Net Borrowings go up and down completely randomly.

Correlation Coefficient

0.38

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Change In Cash

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Most indicators from Shenzhen Glory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shenzhen Glory Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 103.2 M. The current year's Tax Provision is expected to grow to about 34.8 M

	2021	2022	2023	2024 (projected)
Gross Profit	362.9M	221.9M	197.6M	319.4M
Research Development	52.4M	48.2M	40.1M	52.2M

Gross Profit Research Development

Shenzhen Glory fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.73	0.12	0.81	0.94	0.57	0.88	0.77	0.23	0.97	0.72	0.38	0.97	0.7	0.62	0.59	0.78	0.7	0.83	0.46	0.77	0.91	0.94	0.49	0.8	0.94
Short Long Term Debt Total	0.73		-0.1	0.48	0.6	0.35	0.75	0.44	0.56	0.69	0.47	0.24	0.71	0.57	0.95	0.49	0.53	0.97	0.52	0.37	0.37	0.76	0.68	0.34	0.52	0.64
Other Current Liab	0.12	-0.1		0.32	0.05	0.32	0.17	-0.29	0.18	0.08	0.37	-0.33	0.1	-0.19	-0.15	-0.29	0.37	-0.09	0.22	0.31	0.01	0.21	0.14	0.29	0.42	0.1
Total Current Liabilities	0.81	0.48	0.32		0.61	0.76	0.73	0.63	0.29	0.75	0.97	0.09	0.72	0.5	0.29	0.13	0.97	0.4	0.79	0.79	0.39	0.93	0.86	0.8	0.62	0.67
Total Stockholder Equity	0.94	0.6	0.05	0.61		0.39	0.78	0.79	0.05	0.92	0.49	0.47	0.94	0.65	0.55	0.73	0.57	0.61	0.78	0.23	0.92	0.72	0.84	0.24	0.79	0.96
Other Liab	0.57	0.35	0.32	0.76	0.39		0.34	0.46	0.31	0.45	0.72	-0.06	0.51	0.12	0.29	0.02	0.74	0.38	0.51	0.62	0.29	0.74	0.6	0.61	0.51	0.4
Property Plant And Equipment Net	0.88	0.75	0.17	0.73	0.78	0.34		0.51	0.32	0.9	0.72	0.3	0.87	0.75	0.62	0.44	0.76	0.67	0.65	0.44	0.53	0.83	0.82	0.48	0.62	0.83
Current Deferred Revenue	0.77	0.44	-0.29	0.63	0.79	0.46	0.51		0.08	0.76	0.46	0.29	0.77	0.6	0.37	0.49	0.51	0.44	0.74	0.32	0.69	0.67	0.7	0.31	0.58	0.78
Net Debt	0.23	0.56	0.18	0.29	0.05	0.31	0.32	0.08		0.17	0.3	-0.67	0.31	-0.02	0.53	-0.37	0.28	0.55	0.28	0.34	-0.22	0.44	0.09	0.19	0.41	0.26
Retained Earnings	0.97	0.69	0.08	0.75	0.92	0.45	0.9	0.76	0.17		0.66	0.41	0.95	0.82	0.58	0.59	0.74	0.64	0.73	0.41	0.73	0.84	0.89	0.45	0.72	0.91
Accounts Payable	0.72	0.47	0.37	0.97	0.49	0.72	0.72	0.46	0.3	0.66		0.06	0.62	0.44	0.28	0.05	0.97	0.38	0.69	0.78	0.25	0.9	0.8	0.8	0.52	0.56
Cash	0.38	0.24	-0.33	0.09	0.47	-0.06	0.3	0.29	-0.67	0.41	0.06		0.27	0.51	0.22	0.87	0.13	0.21	0.13	-0.09	0.59	0.15	0.5	0.05	-0.02	0.26
Non Current Assets Total	0.97	0.71	0.1	0.72	0.94	0.51	0.87	0.77	0.31	0.95	0.62	0.27		0.68	0.65	0.55	0.67	0.71	0.78	0.33	0.77	0.84	0.83	0.34	0.84	0.97
Other Assets	0.7	0.57	-0.19	0.5	0.65	0.12	0.75	0.6	-0.02	0.82	0.44	0.51	0.68		0.45	0.52	0.54	0.48	0.39	0.31	0.44	0.58	0.66	0.42	0.27	0.6
Long Term Debt	0.62	0.95	-0.15	0.29	0.55	0.29	0.62	0.37	0.53	0.58	0.28	0.22	0.65	0.45		0.53	0.33	0.99	0.41	0.11	0.39	0.62	0.53	0.07	0.49	0.56
Cash And Short Term Investments	0.59	0.49	-0.29	0.13	0.73	0.02	0.44	0.49	-0.37	0.59	0.05	0.87	0.55	0.52	0.53		0.13	0.53	0.37	-0.16	0.82	0.31	0.6	-0.09	0.35	0.57
Net Receivables	0.78	0.53	0.37	0.97	0.57	0.74	0.76	0.51	0.28	0.74	0.97	0.13	0.67	0.54	0.33	0.13		0.43	0.68	0.82	0.33	0.92	0.86	0.83	0.53	0.61
Non Current Liabilities Total	0.7	0.97	-0.09	0.4	0.61	0.38	0.67	0.44	0.55	0.64	0.38	0.21	0.71	0.48	0.99	0.53	0.43		0.5	0.21	0.44	0.71	0.62	0.17	0.57	0.64
Inventory	0.83	0.52	0.22	0.79	0.78	0.51	0.65	0.74	0.28	0.73	0.69	0.13	0.78	0.39	0.41	0.37	0.68	0.5		0.47	0.65	0.81	0.81	0.45	0.82	0.83
Other Current Assets	0.46	0.37	0.31	0.79	0.23	0.62	0.44	0.32	0.34	0.41	0.78	-0.09	0.33	0.31	0.11	-0.16	0.82	0.21	0.47		0.0	0.7	0.61	0.94	0.3	0.31
Other Stockholder Equity	0.77	0.37	0.01	0.39	0.92	0.29	0.53	0.69	-0.22	0.73	0.25	0.59	0.77	0.44	0.39	0.82	0.33	0.44	0.65	0.0		0.48	0.7	0.01	0.68	0.82
Total Liab	0.91	0.76	0.21	0.93	0.72	0.74	0.83	0.67	0.44	0.84	0.9	0.15	0.84	0.58	0.62	0.31	0.92	0.71	0.81	0.7	0.48		0.91	0.68	0.71	0.78
Total Current Assets	0.94	0.68	0.14	0.86	0.84	0.6	0.82	0.7	0.09	0.89	0.8	0.5	0.83	0.66	0.53	0.6	0.86	0.62	0.81	0.61	0.7	0.91		0.63	0.66	0.81
Short Term Debt	0.49	0.34	0.29	0.8	0.24	0.61	0.48	0.31	0.19	0.45	0.8	0.05	0.34	0.42	0.07	-0.09	0.83	0.17	0.45	0.94	0.01	0.68	0.63		0.23	0.29
Intangible Assets	0.8	0.52	0.42	0.62	0.79	0.51	0.62	0.58	0.41	0.72	0.52	-0.02	0.84	0.27	0.49	0.35	0.53	0.57	0.82	0.3	0.68	0.71	0.66	0.23		0.86
Common Stock	0.94	0.64	0.1	0.67	0.96	0.4	0.83	0.78	0.26	0.91	0.56	0.26	0.97	0.6	0.56	0.57	0.61	0.64	0.83	0.31	0.82	0.78	0.81	0.29	0.86

Click cells to compare fundamentals

Shenzhen Glory Account Relationship Matchups

Shenzhen Glory fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.7B	5.1B	5.0B	4.3B	3.9B	3.0B
Short Long Term Debt Total	937.9M	479.9M	392.2M	332.1M	290.6M	248.1M
Other Current Liab	64.5M	5.1M	7.5M	237.1M	24.2M	23.0M
Total Current Liabilities	1.0B	1.0B	1.1B	882.2M	829.8M	821.5M
Total Stockholder Equity	2.3B	3.0B	3.1B	2.8B	2.6B	1.8B
Other Liab	72.8M	76.3M	86.3M	88.4M	101.7M	67.3M
Property Plant And Equipment Net	987.8M	785.1M	637.6M	556.0M	488.8M	483.0M
Current Deferred Revenue	187.5M	387.8M	593.8M	223.6M	402.7M	211.9M
Net Debt	170.6M	(663.4M)	(404.2M)	(153.2M)	(199.7M)	(209.7M)
Retained Earnings	665.3M	772.1M	829.7M	578.7M	429.8M	435.3M
Accounts Payable	641.3M	466.9M	447.1M	380.0M	381.9M	418.5M
Cash	767.3M	1.1B	796.4M	485.2M	490.3M	584.5M
Non Current Assets Total	2.2B	2.5B	2.6B	2.2B	2.1B	1.3B
Other Assets	849.4M	1.1B	1.2B	1.0	1.15	1.09
Long Term Debt	829.0M	301.2M	331.1M	290.6M	269.5M	188.2M
Cash And Short Term Investments	1.1B	1.3B	1.1B	920.1M	818.2M	679.8M
Net Receivables	1.0B	904.1M	871.2M	653.9M	611.0M	714.2M
Liabilities And Stockholders Equity	4.7B	5.1B	5.0B	4.3B	3.9B	3.0B
Non Current Liabilities Total	901.8M	377.4M	417.4M	379.0M	354.2M	227.7M
Inventory	302.9M	343.7M	375.9M	416.8M	371.5M	254.1M
Other Current Assets	111.7M	99.0M	57.4M	37.4M	21.9M	20.8M
Other Stockholder Equity	881.6M	1.3B	1.4B	1.3B	1.3B	836.2M
Total Liab	1.9B	1.4B	1.5B	1.3B	1.2B	1.0B
Total Current Assets	2.5B	2.6B	2.4B	2.0B	1.8B	1.7B
Short Term Debt	108.8M	178.7M	61.1M	41.5M	21.1M	20.0M
Intangible Assets	233.6M	217.2M	275.6M	510.0M	280.4M	173.5M
Common Stock	706.0M	820.3M	844.7M	844.8M	844.8M	484.9M
Property Plant Equipment	987.8M	785.1M	637.6M	556.0M	639.4M	486.3M
Non Currrent Assets Other	1.1B	1.2B	1.4B	1.3B	1.4B	1.5B
Short Term Investments	295.4M	121.1M	292.5M	434.9M	327.9M	344.3M
Net Tangible Assets	2.0B	2.7B	2.8B	2.2B	2.6B	2.2B
Deferred Long Term Liab	7.4M	13.5M	10.9M	6.5M	7.5M	8.4M
Short Long Term Debt	74.1M	138.9M	51.3M	1.9M	1.7M	1.6M
Non Current Liabilities Other	35.6M	829.0M	10.9M	3.7M	4.2M	4.0M
Common Stock Shares Outstanding	706.0M	820.3M	844.7M	844.8M	844.8M	859.9M
Net Invested Capital	3.2B	3.4B	3.5B	3.0B	2.9B	3.3B
Net Working Capital	1.5B	1.6B	1.3B	1.1B	992.9M	1.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Shenzhen Stock

Balance Sheet is a snapshot of the financial position of Shenzhen Glory Medical at a specified time, usually calculated after every quarter, six months, or one year. Shenzhen Glory Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shenzhen Glory and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shenzhen currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shenzhen Change In Cash vs Net Borrowings Analysis

Change In Cash vs Net Borrowings

Change In Cash vs Net Borrowings Correlation Analysis

Correlation Coefficient

Change In Cash

Net Borrowings

Shenzhen Glory fundamental ratios Correlations

Shenzhen Glory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shenzhen Glory fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Shenzhen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 0.99	Long Term Debt
Retained Earnings	+ 0.97	Total Assets
Non Current Assets Total	+ 0.97	Total Assets
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Accounts Payable	+ 0.97	Total Current Liabilities
Net Receivables	+ 0.97	Total Current Liabilities

Cash	- 0.67	Net Debt
Cash And Short Term Investments	- 0.37	Net Debt
Cash	- 0.33	Other Current Liab
Cash And Short Term Investments	- 0.29	Other Current Liab
Current Deferred Revenue	- 0.29	Other Current Liab
Other Stockholder Equity	- 0.22	Net Debt